SCHEMBL24503166

SCHEMBL24503166

COc1ccc(-c2ccc(CCC#N)cc2)cc1N(C)C=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
SLC2A1 P11166 1/20 0.34
KMT2A Q03164 3/20 0.33
ERN1 O75460 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21635975 0.77 ACHE (0.39) CYP3A4KMT2AERN1ALDH1A1LMNA
SCHEMBL11705542 0.69 MAOB (0.59) PDE4DKDM4EALDH1A1MAPTPDE4A
SCHEMBL5446248 0.69 ATM (0.59) PDE4DCYP1A2CYP3A4CYP2D6KMT2A
SCHEMBL9552869 0.68 KMT2A (0.56) PDE4DKMT2AALDH1A1MAPTPDE4A
SCHEMBL23653794 0.68 ACHE (0.48) CYP3A4KMT2AALDH1A1LMNAMAPT
SCHEMBL4247817 0.67 KMT2A (0.48) CYP1A2CYP3A4CYP2D6KMT2AKDM4E
SCHEMBL10667947 0.66 MAPT (0.48) KMT2AKDM4EALDH1A1MAPTL3MBTL1
SCHEMBL11801831 0.66 TSHR (0.63) CYP1A2CYP3A4KMT2ALMNAMEN1
SCHEMBL24915901 0.64 KMT2A (0.47) CYP1A2KMT2AALDH1A1MAPTMMP9
SCHEMBL1343898 0.64 TAAR1 (0.55) KMT2AALDH1A1AOC3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022117059-A1 SMALL MOLECULE INHIBITOR OF CATHEPSIN C AND MEDICINAL USE THEREOF 瑞石生物医药有限公司 2022-06-09 WO disclosed